Abstract
The UK NICE has released guidance on the use of erythropoietin receptor agonists for anaemia induced by cancer treatment.
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have